Does Rallies show Form 4 insider transactions for CLNN?

Yes. Rallies tracks CLNN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CLNN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.

CLNN (Clene Inc. Common Stock) Stock Analysis - Insider Trades

Clene Inc. Common Stock (CLNN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLNN trades at $6.72 with a market cap of $86.76M and a P/E ratio of -1.19. CLNN moved +7.60% today. Year to date, CLNN is +19.79%; over the trailing twelve months it is +165.38%. Its 52-week range spans $2.28 to $13.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces CLNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CLNN stock inside the company?

Recent CLNN insider activity includes Ugwumba Chidozie sold 73.30K, Ugwumba Chidozie sold 22.18K, Ugwumba Chidozie sold 72.88K, Ugwumba Chidozie sold 5.79K, and Ugwumba Chidozie sold 5.74K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CLNN Key Metrics

Key financial metrics for CLNN
Metric	Value
Price	$6.72
Market Cap	$86.76M
P/E Ratio	-1.19
EPS	$-5.67
Dividend Yield	0.00%
52-Week High	$13.50
52-Week Low	$2.28
Volume	201
Avg Volume	0
Revenue (TTM)	$342.00K
Net Income	$-39.40M
Gross Margin	79.53%

Recent CLNN Insider Trades

Ugwumba Chidozie sold 73.30K (~$454.44K) on May 12, 2026.
Ugwumba Chidozie sold 22.18K (~$149.69K) on May 11, 2026.
Ugwumba Chidozie sold 72.88K (~$495.61K) on May 4, 2026.
Ugwumba Chidozie sold 5.79K (~$34.83K) on May 1, 2026.
Ugwumba Chidozie sold 5.74K (~$34.87K) on Apr 30, 2026.

Latest CLNN News

Clene Eyes Q3 2026 CNM-Au8 NDA After Positive FDA Meeting, Raises $35M — May 14, 2026
Clene Prices $7M Offering of 1M Shares at $7 Per Share for NDA Filing — May 5, 2026
Clene Secures $28M Oversubscribed Financing, Eyes NDA Filing by June — Mar 12, 2026
Clene Secures $28M Oversubscribed Offering to Fund NDA, Extend Runway into 2027 — Jan 9, 2026
Clene Inc.’s Chidozie Offloads 3,938 Shares at $6.29 After Prior $6.03 Sale — Jan 9, 2026

CLNN Analyst Consensus

5 analysts cover CLNN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.

Common questions about CLNN

Who is trading CLNN stock inside the company?: Recent CLNN insider activity includes Ugwumba Chidozie sold 73.30K, Ugwumba Chidozie sold 22.18K, Ugwumba Chidozie sold 72.88K, Ugwumba Chidozie sold 5.79K, and Ugwumba Chidozie sold 5.74K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CLNN?: Yes. Rallies tracks CLNN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CLNN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLNN. It does not provide personalized investment advice.